Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 725

Similar articles for PubMed (Select 10201607)

1.
2.

Recurrence after topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren's syndrome.

Hong S, Kim T, Chung SH, Kim EK, Seo KY.

J Ocul Pharmacol Ther. 2007 Feb;23(1):78-82.

PMID:
17341155
3.

[Nonpreserved topical steroids and lacrimal punctal occlusion for severe keratoconjunctivitis sicca].

Sainz De La Maza Serra M, Simón Castellvi C, Kabbani O.

Arch Soc Esp Oftalmol. 2000 Nov;75(11):751-756. Spanish.

4.

Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca.

Pflugfelder SC, Jones D, Ji Z, Afonso A, Monroy D.

Curr Eye Res. 1999 Sep;19(3):201-11.

PMID:
10487957
5.

Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients.

Lee HK, Ryu IH, Seo KY, Hong S, Kim HC, Kim EK.

Ophthalmology. 2006 Feb;113(2):198-205. Epub 2005 Dec 19.

PMID:
16360211
6.

[Oral flaxseed oil (Linum usitatissimum) in the treatment for dry-eye Sjögren's syndrome patients].

Pinheiro MN Jr, dos Santos PM, dos Santos RC, Barros Jde N, Passos LF, Cardoso Neto J.

Arq Bras Oftalmol. 2007 Jul-Aug;70(4):649-55. Portuguese.

7.

Assessing the severity of keratitis sicca with videokeratoscopic indices.

de Paiva CS, Lindsey JL, Pflugfelder SC.

Ophthalmology. 2003 Jun;110(6):1102-9.

PMID:
12799233
8.

Lacrimal punctum occlusion in the treatment of severe keratoconjunctivitis Sicca caused by Sjögren syndrome: a uniocular evaluation.

Mansour K, Leonhardt CJ, Kalk WW, Bootsma H, Bruin KJ, Blanksma LJ; Sjögren Workgroup.

Cornea. 2007 Feb;26(2):147-50.

PMID:
17251802
9.

Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment.

Wilson SE, Perry HD.

Ophthalmology. 2007 Jan;114(1):76-9. Epub 2006 Oct 27.

PMID:
17070588
10.

A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance.

Pflugfelder SC, Maskin SL, Anderson B, Chodosh J, Holland EJ, De Paiva CS, Bartels SP, Micuda T, Proskin HM, Vogel R.

Am J Ophthalmol. 2004 Sep;138(3):444-57.

PMID:
15364229
11.

Systemic immunomodulatory therapy in severe dry eye secondary to inflammation.

Cordero-Coma M, Anzaar F, Sobrin L, Foster CS.

Ocul Immunol Inflamm. 2007 Mar-Apr;15(2):99-104.

PMID:
17558834
12.

Comparison of efficacy and ocular surface toxicity of topical preservative-free methylprednisolone and preserved prednisolone in the treatment of acute anterior uveitis.

Hedayatfar A, Hashemi H, Asgari S, Chee SP.

Cornea. 2014 Apr;33(4):366-72. doi: 10.1097/ICO.0000000000000039.

PMID:
24351572
13.

Ocular surface changes in keratoconjunctivitis sicca with silicone punctum plug occlusion.

Dursun D, Ertan A, Bilezikçi B, Akova YA, Pelit A.

Curr Eye Res. 2003 May;26(5):263-9.

PMID:
12854053
14.

Beneficial effect of topical fibronectin in patients with keratoconjunctivitis sicca of Sjögren's syndrome.

Kono I, Matsumoto Y, Kono K, Ishibashi Y, Narushima K, Kabashima T, Yamane K, Sakurai T, Kashiwagi H.

J Rheumatol. 1985 Jun;12(3):487-9.

PMID:
4045849
15.
16.
17.

Ocular manifestations of Sjögren's syndrome: keratoconjunctivitis sicca.

Friedlaender MH.

Rheum Dis Clin North Am. 1992 Aug;18(3):591-608. Review.

PMID:
1496163
18.

Topical cyclosporine A in severe steroid-dependent childhood phlyctenular keratoconjunctivitis.

Doan S, Gabison E, Gatinel D, Duong MH, Abitbol O, Hoang-Xuan T.

Am J Ophthalmol. 2006 Jan;141(1):62-66.

PMID:
16386977
19.

Preservative-free low-dose dexamethasone for the treatment of chronic ocular surface disease refractory to standard therapy.

Jonisch J, Steiner A, Udell IJ.

Cornea. 2010 Jul;29(7):723-6. doi: 10.1097/ICO.0b013e3181b765a6.

PMID:
20489601
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk